Genome-wide changes in subcutaneous adipose tissue expression in HIV negative adults after 2 weeks of zidovudine or stavudine with lamivudine.
Ontology highlight
ABSTRACT:
ORGANISM(S): Homo sapiens
SUBMITTER: Claudette Satchell
PROVIDER: E-GEOD-34302 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
Similar Datasets
Project description:As controversy remains as to the exact mechanisms by which the thymidine-analogue nucleoside reverse transcriptase inhibitors, zidovudine (AZT) and stavudine (d4T) induce subcutaneous adipose tissue toxicity, we used microarrays to dentify patterns of gene expression in human subcutaneous adipose tissue that change as a result of exposure to these drugs for 2 weeks.
2012-03-15 | GSE34302 | GEO
Project description:Glucocorticoid excess is linked to central obesity, adipose tissue insulin resistance and type 2 diabetes mellitus. The aim of our study was to investigate the effects of dexamethasone on gene expression in human subcutaneous and omental adipose tissue, in order to identify potential novel mechanisms and biomarkers for glucocorticoid-induced insulin resistance in adipose tissue. Dexamethasone changed the expression of 527 genes in both subcutaneous and omental adipose tissue. FKBP5 and CNR1 were the most responsive genes in both depots (~7-fold increase). Dexamethasone increased FKBP5 gene and protein expression in a dose-dependent manner in both depots, but FKBP5 protein levels were 10-fold higher in omental than subcutaneous adipose tissue. FKBP5 gene expression in subcutaneous adipose tissue was positively correlated with serum insulin, HOMA-IR and subcutaneous adipocyte diameter, while fold change in gene expression by dexamethasone was negatively correlated with clinical markers of insulin resistance, i.e. HbA1c, BMI, HOMA-IR and serum insulin. Only one gene, SERTM1, clearly differed in response to dexamethasone between the two depots. Dexamethasone at high concentrations, influences gene expression in both subcutaneous and omental adipose tissue in a similar pattern and promotes gene expression of FKBP5, a gene that may be implicated in glucocorticoid-induced insulin resistance. Paired human subcutaneous (sc) and omental (om) adipose tissue samples obtained from 4 non-diabetic adipose tissue donors (4 M; BMI: 20.8-27.5 Kg/m2) were incubated without (Ctr) or with dexamethasone (Dex, 3 M-NM-<M) for 24 h.
2014-08-18 | E-GEOD-42902 | biostudies-arrayexpress
Project description:Objective: to compare changes in gene expression by microarray from subcutaneous adipose tissue from HIV treatment naïve patients treated with efavirenz based regimens containing abacavir (ABC), tenofavir (TDF) or zidovidine (AZT). There were significant divergence between ABC and the other two groups 6 months after treatment in genes controlling cell adhesion and environmental information processin, with some convergence at 18 months. Compared to HIV negative controls the ABC group, but not AZT or TDF, showed enrichment of genes controlling adherence junction at six months and 184 months (adjusted p <0.05), and cell matrix adhesion (adjusted p<3.4E-0.5) at 6 months. Tight junction (p=0.03), gap junction (p<0.05) and leukocyte transendothelial migration (p=0.03) were over-expressed in ABC compared to TDF at 6 m. Enrichment pathways and individual genes controlling cell adhesion and environmental information processing were specifically dysregulated in the ABC group compared with the other treatments, There was little difference between AZT and TDF. Conclusion: After initiating treatment, there is divergence in the expression of genes controlling cell adhesion and environmental information processing between ABC and both TDF and AZT in subcutaneous adipose tissue. If similar changes are taking place in other tissues including the coronary vasculature, they may contribute to the observed increased risk of cardiovascular events reported in patients recently started on abacavir-containing regimens.
2015-04-16 | GSE62117 | GEO
Project description:We run microarrays from three per group Sv129 female mice, ten weeks old, which were maintained at 28M-BM-0C (warm conditions) or 6M-BM-0 C (cold stimulated) for ten days, while standard animal house temperature is 22 M-BM-0C. After ten days, three types of tissue were collected: Brown Adipose Tissue (BAT), Mesenteric (visceral) White Adipose Tissue (MES) and Posterior Subcutaneous White Adipose Tissue (WAT) Different adipose tissue depots were taken for RNA extraction and hybridization on Affymetrix microarrays. We sought to determine the differences between white and brown adipose tissues at different temperatures
2014-03-01 | E-GEOD-51080 | biostudies-arrayexpress
Project description:Comparing gene expression profiles of murine subcutaneous vs. visceral adipose tissue. Gene expression was analyzed in two subcutaneous depots (inguinal and axillary) and two visceral depots (epididymal and mesenteric) from male C57Bl/6 mice. 4 samples were analyzed as two groups: inguinal and axillary (subcutaneous) and epididymal and mesenteric (visceral). Each sample was derived by pooling RNA from the relevant fat depot from 3 age-matched, male C57Bl6 mice.
2014-01-16 | E-GEOD-53307 | biostudies-arrayexpress
Project description:Expression profiling of progenitor cells from human supraclavicular and subcutaneous adipose tissue. Studies in animal models revealed that brown and white adipocytes derive from different progenitor cells. Molecular characteristics of these cells have not been investigated in detail in humans. Results provide evidence into the molecular basis of the difference of white and brown progenitor cells in humans. Progenitor cells from paired samples of supraclavicular and subcutaneous of six patients undergoing neck surgery were isolated by collagenase digestion and subsequently transferred to cell culture. After reaching subconfluency (7 days), we harvested RNA and analyzed differencens in gene expression by microarray analysis.
2014-08-05 | E-GEOD-54280 | biostudies-arrayexpress
Project description:The adipose tissue is an endocrine regulator and a risk factor for atherosclerosis and cardiovascular disease when by excessive accumulation induces obesity. Although the adipose tissue is also a reservoir for stem cells (ASC) their function and “stemcellness” has been questioned. Our aim was to investigate the mechanisms by which obesity affects subcutaneous white adipose tissue (WAT) stem cells. We used microarrays to analyze differences in transcriptomic profiles between the adipose stem cells from morbidly obese and non-obese individuals. Subcutaneous white adipose tissues that were obtained during bariatric surgery (Obese) or liposuction (Lean) were donated by patients after obtaining informed consent. Three cases with BMI>40 kg/m2 (ASCmo) and three controls with BMI<25 kg/m2 (ASCn) were selected and processed extracting total RNA, processing and hybridizating on microarrays.
2013-09-17 | E-GEOD-48964 | biostudies-arrayexpress
Project description:Objective: to compare changes in gene expression by microarray from subcutaneous adipose tissue from HIV treatment naïve patients treated with efavirenz based regimens containing abacavir (ABC), tenofavir (TDF) or zidovidine (AZT). There were significant divergence between ABC and the other two groups 6 months after treatment in genes controlling cell adhesion and environmental information processin, with some convergence at 18 months. Compared to HIV negative controls the ABC group, but not AZT or TDF, showed enrichment of genes controlling adherence junction at six months and 184 months (adjusted p <0.05), and cell matrix adhesion (adjusted p<3.4E-0.5) at 6 months. Tight junction (p=0.03), gap junction (p<0.05) and leukocyte transendothelial migration (p=0.03) were over-expressed in ABC compared to TDF at 6 m. Enrichment pathways and individual genes controlling cell adhesion and environmental information processing were specifically dysregulated in the ABC group compared with the other treatments, There was little difference between AZT and TDF. Conclusion: After initiating treatment, there is divergence in the expression of genes controlling cell adhesion and environmental information processing between ABC and both TDF and AZT in subcutaneous adipose tissue. If similar changes are taking place in other tissues including the coronary vasculature, they may contribute to the observed increased risk of cardiovascular events reported in patients recently started on abacavir-containing regimens. 31 HIV treatment naïve patients were randomised to receive either zidovidine (AZT)/lamivudine or tenofavir (TDF)/emtricitabine in fixed dose preparations. Both groups also received efavirenz. Patients were tested before treatment (AZT n=15, TDF n=16) and at 6 (AZT n=9, TDF n=12) and 18-24 (AZT n= 8, TDF n=9) months after starting therapy. Tests included extensive biochemical tests, tests of body fat distribution and subcutaneous fat biopsies. 15 HIV negative patients were similarly tested. Patients and controls were matched for age, ethnicity, gender, weight, BMI, pretreatment CD4 count, viral load, and family history of cardiovascular disease and diabetes. In a second part of the study patients on their initial antiretroviral regimen containihg abacavir (ABC)/lamivudine plus efavirenz for 6 months (n=9) and 184 months (n=10) were similarly tested. the ABC-treated group were matched in all the listed characteristice with the other two groups. None of the patients had ever experienced an AIDS-defining disease or developed lipodystrophy over the study period. Fat biopsies were snap frozen until assayed. Microarray methods: RNA was extracted for microarray and array data generated using a Qiagen RNeasy Lipid Tissue Mini Kit. Total RNA was converted into labeled cDNA using the WT-Ovation Pico RNA Amplification System and samples were hybridized to an Agilent Whole Human Genome Microarray 4x44K (AMADID 014850, Agilent Technologies). The Agilent arrays were scanned with the Agilent Technologies DNA Microarray Scanner G2505C with default settings. Scanned images were extracted and initial quality control performed in Agilent Feature Extraction (AFE) software version 10.7.3.1. Additional quality assessment was performed using the R arrayQualityMetrics package. As no major experimental problems could be detected, all microarrays were included in subsequent analysis steps. The dataset was read into R and processed using the Agi4x44PreProcess package with options to use the AFE Processed Signal as foreground signal and BG Used signal as background adjusted signal. The data were then normalized by the quantile method using the limma function normalize Between Arrays. Probeset filtering was performed using the Agi4x44PreProcess filter method using AFE provided flags to identify features with quantification errors of the signal, reducing the 45,015 features on the Agilent Whole Human Genome Microarray 4x44K array by 38%, or 17,264 features. Residual technical batch effects were corrected using the ComBat method implemented in the SVA R package.Since patients were not randomised to the ABC treatment all samples were treated as unrelated. Gene expression differences between treatment arms were assessed using the linear modeling features implemented in the limma package in R. Multiple testing across contrasts was performed using the limma global method with Benjamini-Hochberg approach for control of false discovery rate (FDR). Gene set enrichment analysis of GO terms and KEGG pathways was performed using the conditional hypergeometric test implemented in the GOstats R package. Statistical significance of gene set enrichment was performed using the Benjamini-Hochberg correction method implemented in the EMA R package .
2015-04-16 | E-GEOD-62117 | biostudies-arrayexpress
Project description:Feed efficiency (FE) is an indicator of efficiency in converting energy, attained from macronutrient ingestion, into tissue. Adipose tissue, besides being a master regulator of systemic lipid storage, is also an active endocrine organ that communicates with skeletal muscle, liver and brain to influence appetite, lipid & glucose metabolism and energy homeostasis. Adipose tissue is hypothesised to play a vital part in regulation of FE. The objective of the present study was to sequence the subcutaneous adipose tissue transcriptome in FE-divergent pigs (n=16) and identify relevant biological processes underpinning observed differences in FE.
2018-11-14 | E-MTAB-6255 | biostudies-arrayexpress
Project description:The aim of this study was to undertake an in-depth and comparative study of the protein expression patterns of subcutaneous and visceral adipose tissues in goats, combined to an mRNA expression study of proteins involved in immune and inflammatory response. Samples were obtained from four healthy goat-kids, Alpine breed, naturally reared by their mothers. Animals were slaughtered at the age of 30 days, during routinely slaughtering procedures, and four different adipose tissues were collected from each animal. Subcutaneous fat was taken from sternum and base of the tail; visceral fat was taken from perirenal and omental depots. The four adipose tissues deposits were selected due to their frequent use in experimental studies on fat tissue. Liver samples were also collected, and used as reference samples. Tissue samples were snap frozen in liquid nitrogen and stored at –80 degrees C until analysis. The 20 runs included in this dataset are from the 4 animals x 5 tissues (sternum, base of the tail, perirenal area, omentum and liver). A 2-D label free LC-MS/MS approach followed by cluster analysis was used for comparing the subcutaneous and visceral fat tissue proteomes. Each sample was analysed in ~12 SCX fractions which correspond to the WIFF files included in each RAW_GOAT0xx.zip files.
2015-07-17 | PXD000564 | Pride